ARQT

Arcutis Biotherapeutics, Inc.

Biotechnology · Biotechnology

$82.56 sample

+1.16 (+1.43%) 1D

Market cap

$283.0B

Price as of

2026-10-23

Latest filing

8-K · 2026-10-19

Alerts

8

Price$82.56 +4.16% 3M daily closessample

82.5676.83

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 19SECForm 144 filed
Oct 14INSInsider sell: Chief Financial Officer
Oct 05INSInsider buy: Chief Financial Officer
Sep 28INSInsider buy: Chief Financial Officer
Sep 17INSInsider sell: Chief Executive Officer
Sep 14INSInsider sell: Chief Financial Officer
Sep 07INSInsider sell: Chief Financial Officer
Aug 28INSInsider sell: 10% owner

Sign up to see the real ARQT record →

Company facts

SEC EDGAR registration

Name: Arcutis Biotherapeutics, Inc.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: +24sample, -100 to +100
Reporting currency: USD

Who is positioning in ARQT

sample

Insiders: 15 insider transactions over 90 days, net selling, $719.5M
Congress: 1 members traded over 90 days
Institutions · 13F: 41 funds hold $1.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$16.7B +10.4% y/y

Q4 2024Q3 2026

Inventory$10.0B +11.2% y/y

Q4 2024Q3 2026

Accounts receivable$7.8B +15.9% y/y

Q4 2024Q3 2026

Total debt$20.6B +17.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $244.6B -12.9% 3M
Sample peer B: $246.8B -1.7% 3M
Sample peer C: $187.1B -4.9% 3M
Sample peer D: $215.8B -12.0% 3M
Sample peer E: $98.2B -1.4% 3M